TNF and COVID-19: Previous studies have also reported that overproduction of TNF-α is associated with poor disease outcomes in MERS-CoV and SARS-CoV (50, 56), while administration of anti-TNF-α antibody (certolizumab) may have positive effects on COVID-19 patients (57).